Sign Up to like & get
recommendations!
1
Published in 2022 at "Epilepsia"
DOI: 10.1111/epi.17278
Abstract: A recent Phase II randomized, controlled trial of bumetanide as an adjunctive treatment for neonatal seizures showed a robust efficacy signal and no evidence of toxicity. Concerns regarding bumetanide as an adjunctive anticonvulsant are addressed…
read more here.
Keywords:
bumetanide neonatal;
clarifications regarding;
neonatal seizures;
regarding bumetanide ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Epilepsia"
DOI: 10.1111/epi.17279
Abstract: In his editorial, Kevin Staley criticizes our recent work demonstrating the lack of effect of bumetanide in a novel model of neonatal seizures. The main points in our response are that (1) our work is…
read more here.
Keywords:
brain;
light pharmacokinetic;
bumetanide neonatal;
neonatal seizures ... See more keywords